Evidence map›Paper›PMID 32272700›Full record

ArticlePolymers2020

New Biodegradable Poly(l-lactide)-Block-Poly(propylene adipate) Copolymer Microparticles for Long-Acting Injectables of Naltrexone Drug.

Stavroula Nanaki, Athina Viziridou, Alexandra Zamboulis, Margaritis Kostoglou, Georgios Z Papageorgiou, Dimitrios N Bikiaris

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Polymers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Ultra-Long-Term Delivery of Hydrophilic Drugs Using InjectablebioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Application of Biomedical Microspheres in Wound Healing.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Poly(ethylene glycol)-Molecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Stavroula NanakiLaboratory of Polymer Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-541 24 Thessaloniki, Greece.
Athina ViziridouDepartment of Food Science and Technology, International Hellenic University, GR-57400 Thessaloniki, Greece.
Alexandra ZamboulisLaboratory of Polymer Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-541 24 Thessaloniki, Greece.
Margaritis KostoglouLaboratory of General and Inorganic Chemical Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-541 24 Thessaloniki, Greece.
Georgios Z PapageorgiouChemistry Department, University of Ioannina, P.O. Box 1186, 45110 Ioannina, Greece.
Dimitrios N BikiarisLaboratory of Polymer Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-541 24 Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRInternational Hellenic University · GRUniversity of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, novel block copolymers of poly(l-lactide)-block-poly(propylene adipate) (PLLA-

Indexed as

amphiphilic block copolymerscontrolled releasedrug encapsulationlong-acting injectablesmicrospheresnaltrexonepoly(L-lactide)poly(propylene adipate)

Identifiers

PMID32272700
PMCPMC7240759
OpenAlexW3016205181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.